New Computational Tools for Modeling Chronic Myelogenous Leukemia
From MaRDI portal
Recommendations
- A mathematical model of Imatinib and interferon-Alpha combined treatment of chronic myeloid leukemia
- A mathematical model with time-varying delays in the combined treatment of chronic myeloid leukemia
- Stability and controllability issues in mathematical modeling of the intensive treatment of leukemia
- Optimal control analysis of a leukemia model under Imatinib treatment
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
Cited in
(6)- Using mathematical models to improve risk-scoring in acute myeloid leukemia
- Data and implication based comparison of two chronic myeloid leukemia models
- B cell chronic lymphocytic leukemia - a model with immune response
- Stability analysis of a mathematical model for chronic myeloid leukemia eradication
- Progression, detection and remission: evolution of chronic myeloid leukemia using a three-stage probabilistic model
- Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models
This page was built for publication: New Computational Tools for Modeling Chronic Myelogenous Leukemia
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3627332)